Literature DB >> 17135772

Intraductal papillary mucinous neoplasms and chronic pancreatitis.

Giorgio Talamini1, Giuseppe Zamboni, Roberto Salvia, Paola Capelli, Nora Sartori, Luca Casetti, Paolo Bovo, Bruna Vaona, Massimo Falconi, Claudio Bassi, Aldo Scarpa, Italo Vantini, Paolo Pederzoli.   

Abstract

BACKGROUND: Intraductal papillary mucinous neoplasms (IPMNs) may present with clinical and radiological pictures resembling those of chronic pancreatitis (CP). AIMS: To compare the clinical and epidemiological characteristics of patients suffering from CP with those of patients suffering from IPMN. To assess whether CP is associated with an increased risk of developing IPMN.
METHODS: In our departments, from 1981 to 1998, we prospectively followed 473 patients suffering from CP, including 93 cases of chronic obstructive pancreatitis (COP), and 45 patients with a histologically confirmed diagnosis of IPMN. Another 6 patients had an initial diagnosis of CP and a subsequent diagnosis of IPMN.
RESULTS: Patients with IPMN were more often female (females 53 vs. 15%; p < 0.001), were older (mean age 63.1 vs. 42.8 years; p < 0.001), drank less alcohol (19 vs. 107 g/day; p < 0.001) and smoked fewer cigarettes (mean 8 vs. 21 cigarettes/day) than CP patients. These results were also confirmed when considering only patients with COP. The 6 patients with a subsequent diagnosis of IPMN were males (p n.s.) with a mean age of 51.4 years (p < 0.05). Only 1 patient was a drinker (p < 0.05) and 4 were smokers (p n.s.). Comparing CP and IPMN, logistic regression analysis selected sex, age, alcohol and smoking, whereas only sex and age were selected when comparing COP vs. IPMN.
CONCLUSIONS: In general patients with IPMN present different epidemiological characteristics than those with CP and the subgroup with COP. The clinical and pathological features suggest that in most cases IPMN is the cause of CP and not vice versa. Copyright 2006 S. Karger AG, Basel and IAP.

Entities:  

Mesh:

Year:  2006        PMID: 17135772     DOI: 10.1159/000097605

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  18 in total

1.  Intraductal papillary mucinous neoplasm in chronic calcifying pancreatitis: egg or hen?

Authors:  Evangelos Kalaitzakis; Barbara Braden; Palak Trivedi; Yalda Sharifi; Roger Chapman
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

2.  Endoscopic treatment for pancreatic diseases: Needle-knife-guided cannulation via the minor papilla.

Authors:  Wei Wang; Biao Gong; Wei-Song Jiang; Lei Liu; Kouken Bielike; Bin Xv; Yun-Lin Wu
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

3.  MRCP Imaging of Intraductal Papillary-Mucinous Neoplasm of the Pancreas.

Authors:  Mecit Kantarci; Ummugulsum Bayraktutan; Omer Yılmaz; Dilek Karatas
Journal:  Eurasian J Med       Date:  2012-04

Review 4.  Pancreatic cysts: a systematic approach and second look.

Authors:  Dennis Emuron; Viplove Senadhi; Sean Teagarden; Vinod K Parasher
Journal:  J Gastrointest Cancer       Date:  2012-12

5.  Population-based epidemiology, risk factors and screening of intraductal papillary mucinous neoplasm patients.

Authors:  Saboor Khan; Guido Sclabas; Kaye M Reid-Lombardo
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 6.  Endoscopic management of complications of chronic pancreatitis.

Authors:  Jean-Marc Dumonceau; Carlos Macias-Gomez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 7.  Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment.

Authors:  Robert Grützmann; Marco Niedergethmann; Christian Pilarsky; Günter Klöppel; Hans D Saeger
Journal:  Oncologist       Date:  2010-12-08

Review 8.  Endoscopic therapy in acute recurrent pancreatitis.

Authors:  John Baillie
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

9.  Intraductal papillary mucinous neoplasm presenting with recurrent pancreatitis: a report of a painful 3-decade-long history.

Authors:  Samuel Raimundo Fernandes; Luís Araújo Correia; Teresa Antunes; Helena Cortez-Pinto
Journal:  BMJ Case Rep       Date:  2016-03-21

10.  Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.

Authors:  Claudio Sorio; Andrea Mafficini; Federico Furlan; Stefano Barbi; Antonio Bonora; Giorgio Brocco; Francesco Blasi; Giorgio Talamini; Claudio Bassi; Aldo Scarpa
Journal:  BMC Cancer       Date:  2011-10-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.